Peer-reviewedCC BY 4.0Frontiers in Oncology
Editorial: Dysbiosis and microbiome modulation in cancer prevention and therapy
- 1Department of Medical Biotechnology, Gujarat Biotechnology University (GBU)
- 2Yitzhak Shamir Medical Center (formerly Assaf Harofeh Medical Center)
- 3Department of Molecular Biology & Biochemistry, Guru Nanak Dev University (GNDU)
Related
- EpOMEs Compromise Colonic Homeostasis Through Microbiome Dysbiosis and Inflammatory Activation
- Gut microbiota modulation of gastrointestinal cancers: from dysbiosis signatures to therapeutic interventions
- Gut Microbiome Dysbiosis in Metabolic Syndrome: Current Evidence and Emerging Perspectives
- The Oral–Gut–Systemic Axis in Periodontitis: Microbiome Dysbiosis, Immune Crosstalk and Translational Perspectives
- Dynamic Gut-Lung Microbiome Interactions Beyond Dysbiosis Across the Course of COPD.
BibTeX
@article{nair2026editorial,
title = {{Editorial: Dysbiosis and microbiome modulation in cancer prevention and therapy}},
author = {Rohini Ravindran Nair and Ehud Wainstein and Suresh Singh Yadav},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.2006794},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.2006794/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Dysbiosis and microbiome modulation in cancer prevention and therapy
AU - Rohini Ravindran Nair
AU - Ehud Wainstein
AU - Suresh Singh Yadav
PY - 2026
DA - 2026/10/19
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.2006794
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.2006794/full
SN - 2234-943X
ER -